| TH | tension headache; tetrahydrocortisol; T helper [cell]; theophylline; thorax; thrill; thyrohyoid; thy... |
|---|---|
| TMR | tissue maximum ratio; topical magnetic resonance; trainable mentally retarded |
| top | topical |
| VF | 1) Ventricular Fibrillation ? Tx of Ventricular Fibrillation ... |
| WPW Syndrome | Wolff-Parkinson-White Syndrome ? CIx 1. Drugs; AV Conduct... |
| TMR | Topical Magnetic Resonance |
|---|---|
| L | Lidocaine |
| LID | Lidocaine |
| xylocaine | Lidocaine |
| lidocaine | Lignocaine |
oral (경구, 입의, 경구의, 구강, 구강의
| lidocaine | <cardiology, drug> A local anaesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine. Pharmacological action: anaesthetics, local, anti-arrhythmia agents. Decreases automaticity, depresses conduction in reentrant pathways and may raise fibrillation threshold, especially in combination with bretylium. Uses: The drug of first choice for ventricular arrhythmias, ventricular ectopy, and wide complex tachycardias of unknown origin. Dose: 1-1.5 mg/kg IV bolus, followed by additional 0.5-1.5 mg/kg every 5-10 min to a total of 3 mg/kg. Can be administered via the endotracheal tube. Use 2 to 2.5 times the intravenous dose. Upon return of circulation, use continuous infusion at 2 - 4 mg/min. Reduce the maintenance dose if decreased cardiac output or hepatic failure or more than 70 years of age. Potential complications: dizziness, drowsiness, disorientation, seizures, hypotension - causes vasodilation; myocardial depression at higher concentrations; heart block - only rarely seen with high levels. Chemical name: 2-(diethylamino)-N-(2,6-dimethylphenyl)-acetamide (15 Mar 2000) |
|---|---|
| lidocaine N-deethylase | <enzyme> Catalyzed mainly by cytochrome p-450 3a2 in rat liver microsomes Registry number: EC 1.- (26 Jun 1999) |
| anti-inflammatory agent, topical | Anti-inflammatory agent that are applied to the skin and whose pharmacological effect only occurs at the area of application. (12 Dec 1998) |
| glucocorticoids, topical | A class of corticosteroids that produces suppression of inflammatory diseases when applied as ointments, lotions, or other topical dosage forms. Penetration of the preparations may be increased by means of occlusive dressings. (12 Dec 1998) |
| prednisolone, topical | Prednisolone that is applied topically as an anti-inflammatory agent. (12 Dec 1998) |
| hydrocortisone, topical | Hydrocortisone that is applied topically as an anti-inflammatory agent. (12 Dec 1998) |
| topical | <pharmacology> Pertaining to a particular surface area, as a topical anti-infective applied to a certain area of the skin and affecting only the area to which it is applied. Origin: Gr. Topikos (18 Nov 1997) |
| topical anaesthesia | Superficial loss of sensation in conjunctiva, mucous membranes or skin, produced by direct application of local anaesthetic solutions, ointments, or jellies. (05 Mar 2000) |
| topical anaesthetic | An anaesthetic that is applied or sprayed on the surface of the skin (or mucous membranes) for providing pain relief. Commonly used are benzocaine, butacaine, cyclomethycaine, lidocaine, tetracaine and dibucaine. (27 Sep 1997) |
| topical antibiotics | A ointment (or cream) based medication that kills bacteria. Examples include Neosporin, Bactroban, Garamycin, bacitracin, gentamicin, mupirocin, neomycin, silver sulphasalazine, chloramphenicol and clindamycin. (27 Sep 1997) |
| topical chemotherapy | Treatment with anticancer drugs in a lotion or cream. (12 Dec 1998) |
| fluorides, topical | Fluorides, usually as pastes or gels, used for topical application to reduce the incidence of dental caries. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|